Summary of opinion: Elucirem, 11/12/2025 Positive
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Summary of opinion: Elucirem, 11/12/2025 Positive
Summary of opinion: Vueway, 11/12/2025 Positive
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Summary of opinion: Vueway, 11/12/2025 Positive
Summary of opinion: Eylea, 11/12/2025 Positive
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Summary of opinion: Eylea, 11/12/2025 Positive
Summary of opinion: Nucala, 11/12/2025 Positive
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Summary of opinion: Nucala, 11/12/2025 Positive
Summary of opinion: Hetlioz, 11/12/2025 Negative
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Summary of opinion: Hetlioz, 11/12/2025 Negative
Human medicines European public assessment report (EPAR): Blarcamesine Anavex, blarcamesine, Status: Opinion
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Human medicines European public assessment report (EPAR): Blarcamesine Anavex, blarcamesine, Status: Opinion
Summary of opinion: Mounjaro, 11/12/2025 Positive
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Summary of opinion: Mounjaro, 11/12/2025 Positive
Summary of opinion: Uplizna, 11/12/2025 Positive
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Summary of opinion: Uplizna, 11/12/2025 Positive
Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Application withdrawn
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Application withdrawn
Summary of opinion: Arexvy, 11/12/2025 Positive
Submitted by Anonymous (not verified) on 12 December 2025 - 13:00
Summary of opinion: Arexvy, 11/12/2025 Positive